Elevance Health Stock Hits Day Low of $274.90 Amid Price Pressure

Elevance Health, Inc. experienced a notable decline today, with the stock dropping by 3.07% on March 9, 2026. The stock reached an intraday low of USD 274.90, reflecting ongoing challenges in its performance metrics. Over the past week, Elevance Health has seen a decrease of 4.53%, while its performance over the last month has been even more pronounced, with a decline of 14.28%. In the context of the broader market, the S&P 500 has shown a positive performance of 0.83% today, contrasting sharply with Elevance Health's struggles. Year-to-date, the stock is down 19.91%, and over the past year, it has faced a significant drop of 31.44%. Despite these challenges, Elevance Health maintains a large market capitalization of USD 75,686 million and a price-to-earnings ratio of 15.00. The company has demonstrated a return on equity of 12.90%, although it has faced consistent underperformance against the S&P 500 over the last three years. The stock's current valuation reflects a price-to-book ratio of 1.72, indicating a discount compared to its peers.